| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Oct―31 |
Potential Signals of COVID-19 as an Effect Modifier of Adverse Drug Reactions |
Manfred Hauben, Eric Hung, Yan Chen |
| 2 |
[GO] |
2023―Oct―30 |
Cost-effectiveness Analysis and Impact on Length of Hospital Stay of the Introduction of Remdesivir as a Treatment Option for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen in Greece Versus Standard of Care |
Kostas Athanasakis, Konstantinos Zisis, Christos Tsoulas, Nikolaos Nomikos |
| 3 |
[GO] |
2023―Sep―26 |
The Utility of a Social Listening Program to Support Safety Surveillance of Tozinameran (COVID-19 Vaccine)-a Brief Survey of Pharmacovigilance Professionals |
Manfred Hauben |
| 4 |
[GO] |
2023―Sep―26 |
Intersection of Coronavirus Disease 2019 and Alcohol-associated Liver Disease: A Review of Emerging Trends and Implications |
Elizabeth S. Aby, Alexander S. Vogel, Adam C. Winters |
| 5 |
[GO] |
2023―Jul―29 |
Long COVID-19 and Insulin Autoimmune Syndrome: A Case Report |
Fernanda Isadora Corona-Meraz, Blanca Perla Quintero-Castillo, Luis Alexis Hernández-Palma, Andrea Carolina Machado-Sulbaran |
| 6 |
[GO] |
2023―Apr―27 |
Drug-Drug Interactions - An Overlooked Dimension of the COVID-19 Pandemic |
Paul Beninger |
| 7 |
[GO] |
2023―Mar―24 |
Prevalence of Potential Drug-Drug Interactions with Ritonavir-Containing COVID-19 therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey |
Ebuwa Igho-Osagie, Kaylen Brzozowski, Harry Jin, Jeffrey Brown, Marissa Grifasi Williams, Amy Puenpatom |
| 8 |
[GO] |
2023―Jan―16 |
The impact of the COVID-19 pandemic on antiasthmatics’ prescription: a nationwide study |
Tânia Magalhães Silva, Bernardo Sousa Pinto, Inês Cunha, Fátima Roque, Adolfo Figueiras, João Fonseca, Maria Teresa Herdeiro, Eva Rebelo Gomes |
| 9 |
[GO] |
2022―Oct―24 |
Immunogenicity and Safety of SpikoGen®, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-Arm Clinical Trial |
Mohsen Nafar, Narges Mostafaloo, Ahmad Firouzan, Fatemeh Poorrezagholi, Fariba Samadian, Nooshin Dalili, Saghar Barati, Nassim Anjidani, Hamidreza Kafi, Ramin Shahpari, Mahdiye Bayat, Soha Kianipour, Shiva Samavat |
| 10 |
[GO] |
2022―Jul―25 |
Effects of the COVID-19 Pandemic on Pharmacovigilance Strategy, Systems and Processes of Large, Medium, and Small Companies: An Industry Survey |
Paul Beninger, Patrick Caubel, Latika Sharma, Geo Pajovich, Pete Boyd |
| 11 |
[GO] |
2022―May―13 |
Reproductive Health and Coronavirus Disease 2019-Induced Economic Contracture: Lessons From the Great Recession |
LeAnn Louis, Angela Frankel, Asha Ayub, Tatum Williamson, Ashley Hanes, Megan L. Evans |
| 12 |
[GO] |
2022―Jan―29 |
Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-Based Pediatric COVID-19 Vaccine Delivery |
Annika M. Hofstetter, Suchitra Rao, Ravi Jhaveri |
| 13 |
[GO] |
2022―Jan―17 |
Early use of remdesivir and risk of disease progression in hospitalized patients with mild-to moderate COVID-19 |
Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, Chiara Barbieri, Lisa Giusti, Valentina Galfo, Arianna Forniti, Claudio Caroselli, Leonardo Della Sala, Sara Tempini, Chukwuma Okoye, Fabio Monzani, Francesco Menichetti |
| 14 |
[GO] |
2022―Jan―10 |
COVID-19 made the impossible possible - Rolling Reviews from a notion to reality - the EU experience put into a global context |
Roelie Marinus, Sarah Mofid, Marya Mpandzou, Thomas C. Kühler |
| 15 |
[GO] |
2021―Nov―25 |
One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business |
Ravi Jhaveri |
| 16 |
[GO] |
2021―Nov―16 |
Willingness to Accept Expedited COVID-19 Vaccine Research for Children Under 12 Years after Adult Vaccine Approval |
Ran D. Goldman, Jeffrey N Bone, Renana Gelernter, Danna Krupik, Eileen J. Klein, Mark A. Griffiths, Ahmed Mater |
| 17 |
[GO] |
2021―Oct―13 |
The utility of remote inspections during the COVID-19 health emergency and in the post-pandemic setting |
Sarah Mofid, Winona Rei Bolislis, Clive Brading, Nigel Hamilton, Cyril Hardit, Makoto Nagaoka, Julien Parain, Maria Zanta, Thomas C. Kühler |
| 18 |
[GO] |
2021―Oct―04 |
Cost-effectiveness of Baricitinib Compared with Standard of Care in Hospitalized Patients With COVID-19 in the United States: A Modelling Study |
Robert Ohsfeldt, Kari Kelton, Tim Klein, Mark Belger, Patrick L. Mc Collam, Theodore Spiro, Russel Burge, Neera Ahuja |
| 19 |
[GO] |
2021―Sep―10 |
How COVID-19 is Helping Us Learn More about Diabetes Pathogenesis |
Ravi Jhaveri |
| 20 |
[GO] |
2021―Aug―23 |
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled Phase 1 Studies in Healthy Subjects and Patients with Mild SARS-CoV-2 Infection |
Jin Yong Kim, Young Rock Jang, Jang Hee Hong, Jin Gyu Jung, Jae-Hyeong Park, Adrian Streinu-Cercel, Anca Streinu-Cercel, Oana Săndulescu, Sang Joon Lee, Sung Hyun Kim, Na Hyun Jung, Seul Gi Lee, Jeong Eun Park, Min Kyung Kim, Da Bee Jeon, Yeo Jin Lee, Bum Soo Kim, Yeon Mi Lee, Yeon-Sook Kim |
| 21 |
[GO] |
2021―Aug―05 |
Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
Leila Shahbaznejad, Alireza Davoudi, Gohar Eslami, John S. Markowitz, Mohammad Reza Navaeifar, Fatemeh Hosseinzadeh, Faeze Sadat Movahedi, Mohammad Sadegh Rezai |
| 22 |
[GO] |
2021―Jul―26 |
Conversations with the Editors: The Emergence of Variants Amidst Population-Wide SARS-CoV-2 Vaccination Efforts-How Much Should We Worry? |
Egon Ozer, Larry K. Kociolek, Ravi Jhaveri |
| 23 |
[GO] |
2021―Jul―12 |
Ivermectin for coronavirus disease 2019: Yet to be well evaluated before clinical use |
Hideharu Hagiya, Fumio Otsuka |
| 24 |
[GO] |
2021―May―24 |
Exploration and Ethical Analysis of Open-Label Pediatric Vaccine Trials in a Pandemic |
Ian D. Wolfe, Angira Patel, Larry K. Kociolek, Asma Fazal, Ravi Jhaveri, John D. Lantos |
| 25 |
[GO] |
2021―May―06 |
Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial |
Leila Shahbaznejad, Alireza Davoudi, Gohar Eslami, John S. Markowitz, Mohammad Reza Navaeifar, Fatemeh Hosseinzadeh, Faeze Sadat Movahedi, Mohammad Sadegh Rezai |
| 26 |
[GO] |
2021―May―06 |
SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations |
Ian D. Wolfe, Sameer J. Patel |
| 27 |
[GO] |
2021―May―05 |
COVID-19 Vaccine Effectiveness |
Richard I. Shader |
| 28 |
[GO] |
2021―Apr―16 |
Medication utilization among COVID-19 patients in a large, national dataset: Cerner Real-World Data™ |
Stephanie J. Stroever, Daniel Ostapenko, Robyn Scatena, Daniel Pusztai, Lauren Coritt, Paul Nee |
| 29 |
[GO] |
2021―Mar―29 |
Using Machine Learning as a Precision Medicine Approach for Remdesivir and Corticosteroids as COVID-19 Pharmacotherapies |
Carson Lam, Anna Siefkas, Nicole S. Zelin, Gina Barnes, R. Phillip Dellinger, Jean-Louis Vincent, Gregory Braden, Hoyt Burdick, Jana Hoffman, Jacob Calvert, Qingqing Mao, Ritankar Das |
| 30 |
[GO] |
2021―Mar―23 |
The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World |
Ravi Jhaveri |
| 31 |
[GO] |
2021―Mar―20 |
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic |
Eman M. Alfadhli |
| 32 |
[GO] |
2021―Feb―26 |
Inpatient omission of ACEi and ARBs is associated with morbidity and mortality in COVID-19 |
Christopher Oddy, Jonathan Allignton, James McCaul, Polly Keeling, Dhanuja Senn, Neesha Soni, Hannah Morrison, Ruwani Mawella, Thomas Samuel, John Dixon |
| 33 |
[GO] |
2021―Jan―22 |
The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning? |
Ravi Jhaveri |
| 34 |
[GO] |
2021―Jan―18 |
Sex- or gender-specific differences in the clinical presentation, outcome, and treatment of Sars-Cov2 |
Jeannette Wolfe, Basmah Safdar, Tracy E. Madsen, Kinjal N. Sethuraman, Bruce Becker, Marna Rayl Greenberg, Alyson J. McGregor |
| 35 |
[GO] |
2021―Jan―15 |
Influence of COVID-19 on the Pharmacovigilance Workforce of the Future |
Paul Beninger |
| 36 |
[GO] |
2021―Jan―11 |
A critical appraisal of the effects of anesthetics on immune system modulation in critically ill patients with COVID-19 |
Athanasios Chalkias, Erin F. Barreto, Eleni Laou, Konstantina Kolonia, Marc H. Scheetz, Konstantinos Gourgoulianis, Ioannis Pantazopoulos, Theodoros Xanthos |
| 37 |
[GO] |
2021―Jan―08 |
Differential expression of Rab5 and Rab7 small GTPase proteins in placental tissues from pregnancies affected by maternal COVID-19 |
Yoel Benarroch, Lillian Juttukonda, Vishakha Sabharwal, Jeffery Boateng, Amir R. Khan, Christina Yarrington, Elisha M. Wachman, Elizabeth Taglauer |
| 38 |
[GO] |
2020―Dec―18 |
Global and Country Level Time Series Analyses of the Effect of the COVID-19 Pandemic on Spontaneous Reporting |
Manfred Hauben, Eric Hung |
| 39 |
[GO] |
2020―Nov―30 |
Regulatory agilities in the time of COVID-19: Overview, Trends and Opportunities |
Winona Rei Bolislis, Maria Lucia De Lucia, Felipe Dolz, Runyi Mo, Makoto Nagaoka, Heraclio Rodriguez, MayLi Woon, Wei Yu, Thomas C. Kühler |
| 40 |
[GO] |
2020―Oct―03 |
Caregivers’ willingness to accept expedited vaccine research during the COVID-19 pandemic - a cross sectional survey |
Ran D. Goldman, Shashidhar R. Marneni, Michelle Seiler, Julie C. Brown, Eileen J. Klein, Cristina Parra Cotanda, Renana Gelernter, Tyler D. Yan, Julia Hoeffe, Adrienne L. Davis, Mark A. Griffiths, Jeanine E. Hall, Gianluca Gualco, Ahmed Mater, Sergio Manzano, Graham C. Thompson, Sara Ahmed, Samina Ali, Naoki Shimizu, Sarah Ahmed, Samina Ali, Julie C. Brown, Adrienne L. Davis, Nathalie Gaucher, Gualco Gianluca, Ran Goldman, Mark Griffiths, Jeanine E. Hall, Matt Hansen, Tomohiro Katsuta, Christopher Kelly, Eileen J. Klein, Eran Kozer, Ahmed Mater, Rakesh Mistry, Cristina Parra, Naveen Poonai, David Sheridan, Naoki Shimizu, Esther L. Yue |
| 41 |
[GO] |
2020―Aug―17 |
CoVid-19, Microthromboses and Platelet Activating Factor (PAF) |
Theoharis C. Theoharides, Smaragdi Antonopoulou, Constantinos A. Demopoulos |
| 42 |
[GO] |
2020―Jun―28 |
Covid-19: The Regulatory Landscape of Medicinal and Medical Device Products for Human Use |
Paul Beninger |
| 43 |
[GO] |
2020―Apr―27 |
Association Between Clinical Manifestations and Prognosis in Patients with COVID-19 |
Tao Yu, Shaohang Cai, Zhidan Zheng, Xuejuan Cai, Yuanyuan Liu, Sichun Yin, Jie Peng, Xuwen Xu |
| 44 |
[GO] |
2020―Apr―27 |
COVID-19 and Depression |
Richard I. Shader |
| 45 |
[GO] |
2020―Apr―11 |
Echoes of 2009 Pandemic H1N1 Influenza with the COVID Pandemic |
Ravi Jhaveri |
|
